Caricamento...
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. In an earlier version of this review, we found that 5‐ASA drugs were more effective than...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2020
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094989/ https://ncbi.nlm.nih.gov/pubmed/32856298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000544.pub5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|